RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Chougule, Mahavir
PropertyValue
overview Mahavir B. Chougule, Assistant Professor of the Department of Pharmaceutical Sciences, College of Pharmacy, University of Hawaii at Hilo, HI, USA, investigates the use of therapeutic agent, siRNA, proteins and targeted nanotechnology based formulations for treatment of cancer and pulmonary disorders. His research work is focused on targeted delivery using nanocarriers to improve the efficacy and minimize the adverse side effects. Chougule has shown that the inhalation delivery of anticancer drug loaded nanoparticle significantly inhibits tumor growth compared to aerosolized solution. Chougule has also investigated the anticancer activity and molecular mechanism of natural compounds against lung and breast cancer. He also developed the spray dried nano-liposomal dry powder inhalers and topical nanocarrier cream formulation for treatment of skin disorders. Dr. Chougule has more than 7 years of professional experience in developmental therapeutics and biopharmaceuticals. he has has published 21 research articles, 2 review article, 4 book chapters, and presented work in more than 50 scientific conferences. In addition, he is also an inventor in the 8 patents. He is also serving as member of editorial board on 5 international journals and recipient of several awards including AACR Minority-Serving Institution Faculty Scholar in Cancer Research Awards. Research Interests: Cancer, asthma, nanotechnology, small compound and gene/protein based drug delivery, Inhalation delivery, topical/transdermal delivery, Molecular biology, cell culture, and animal models.
One or more keywords matched the following items that are connected to Chougule, Mahavir
Item TypeName
Academic Article Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
Academic Article EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
Academic Article Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.
Academic Article Theranostic tumor homing nanocarriers for the treatment of lung cancer.
Academic Article Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.
Academic Article Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Academic Article Progress in Topical siRNA Delivery Approaches for Skin Disorders.
Academic Article Factorial Design Based Multivariate Modeling and Optimization of Tunable Bioresponsive Arginine Grafted Poly(cystaminebis(acrylamide)-diaminohexane) Polymeric Matrix Based Nanocarriers.
Academic Article Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Academic Article Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.
Academic Article Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
Academic Article Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
Academic Article An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration.
Academic Article Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications.
Concept Nanoparticles
Academic Article Advances in nanoparticle mediated targeting of RNA binding protein for cancer.
Academic Article Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy.
Academic Article Instigation of the epoch of nanovaccines in cancer immunotherapy.
Search Criteria
  • Nanoparticles
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support